Translocator protein (18 kDa) is involved in primitive erythropoiesis in zebrafish
- Rampon, C., Bouzaffour, M., Ostuni, M.A., Dufourcq, P., Girard, C., Freyssinet, J.M., Lacapere, J.J., Schweizer-Groyer, G., and Vriz, S.
- FASEB journal : official publication of the Federation of American Societies for Experimental Biology 23(12): 4181-4192 (Journal)
- Registered Authors
- Dufourcq, Pascale, Vriz, Sophie
- MeSH Terms
- Amino Acid Sequence
- Biological Evolution
- Carrier Proteins/genetics
- Carrier Proteins/metabolism*
- Gene Expression Regulation, Developmental/drug effects
- Gene Expression Regulation, Developmental/physiology*
- Gene Silencing
- Molecular Sequence Data
- Receptors, GABA/genetics
- Receptors, GABA/metabolism*
- Zebrafish Proteins/genetics
- Zebrafish Proteins/metabolism*
- 19723704 Full text @ FASEB J.
Rampon, C., Bouzaffour, M., Ostuni, M.A., Dufourcq, P., Girard, C., Freyssinet, J.M., Lacapere, J.J., Schweizer-Groyer, G., and Vriz, S. (2009) Translocator protein (18 kDa) is involved in primitive erythropoiesis in zebrafish. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 23(12):4181-4192.
The translocator protein (18 kDa) (TSPO), also known as peripheral-type benzodiazepine receptor, is directly or indirectly associated with many biological processes. Although extensively characterized, the specific function of TSPO during development remains unclear. It has been reported that TSPO is involved in a variety of mechanisms, including cell proliferation, apoptosis, regulation of mitochondrial functions, cholesterol transport and steroidogenesis, and porphyrin transport and heme synthesis. Although the literature has reported a murine knockout model, the experiment did not generate information because of early lethality. We then used the zebrafish model to address the function of tspo during development. Information about spatiotemporal expression showed that tspo has a maternal and a zygotic contribution which, during somatogenesis, seems to be erythroid restricted to the intermediate cell mass. Genetic and pharmacological approaches used to invalidate Tspo function resulted in embryos with specific erythropoietic cell depletion. Although unexpected, this lack of blood cells is independent of the Tspo cholesterol binding site and reveals a new in vivo key role for Tspo during erythropoiesis.
Genes / Markers
Mutation and Transgenics
Human Disease / Model Data
Sequence Targeting Reagents
Engineered Foreign Genes
Errata and Notes